Carregant...
The Principles of Engineering Immune Cells to Treat Cancer
Chimeric antigen receptor (CAR) T cells have proven that engineered immune cells can serve as a powerful new class of cancer therapeutics. Clinical experience has helped to define the major challenges that must be met to make engineered T cells a reliable, safe, and effective platform that can be de...
Guardat en:
| Publicat a: | Cell |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5553442/ https://ncbi.nlm.nih.gov/pubmed/28187291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cell.2017.01.016 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|